Stock LQDA LIQUIDIA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Liquidia Corporation

Equities

LQDA

US53635D2027

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-13 pm EDT 		5-day change 1st Jan Change
13.43 USD +0.83% Intraday chart for Liquidia Corporation -3.52% +11.64%
Jun. 03 Liquidia's Yutrepia Launch Cleared as Court Denies Injunction MT
Jun. 03 Liquidia Shares Jump on Latest Favorable Court Ruling for Yutrepia DJ

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Liquidia's Yutrepia Launch Cleared as Court Denies Injunction
MT
Liquidia Shares Jump on Latest Favorable Court Ruling for Yutrepia
DJ
District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ Launch
GL
District Court Issues Favorable Ruling and Denies United Therapeutics? Request to Block YUTREPIA? Launch
CI
Liquidia Corporation to Present at the 2024 Jefferies Global Healthcare Conference
GL
Transcript : Liquidia Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 05:01 PM
Transcript : Liquidia Corporation, Q1 2024 Earnings Call, May 14, 2024
Liquidia Corporation Reports First Quarter 2024 Financial Results and Provides Corporate Update
GL
Liquidia Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Liquidia Announces Poster Presentation at the American Thoracic Society 2024 International Conference on Its Open-Label Safety Study of L606 in Patients with PAH and PH-ILD
AQ
Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients with PAH and PH-ILD
GL
Liquidia Corporation to Present at BofA Securities Health Care Conference 2024
GL
Liquidia Corporation to Present at BofA Securities Health Care Conference 2024
AQ
Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024
GL
Liquidia Corporation to Report First Quarter 2024 Financial Results on May 14, 2024
AQ
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
GL
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
AQ
Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension
MT
Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling
DJ
Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LQDA Stock
  4. News Liquidia Corporation